Government Decree No. 184 / 2021 Coll.
Government Regulation amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended
Valid
Regulation
Effective from 03.06.2021
Text versions:
03.06.2021
07.05.2021
184
GOVERNMENT REGULATION
of 19 April 2021
amending Government Regulation No 463 / 2013 Coll., on substance lists, as amended
The Government orders pursuant to § 44c (1) of Act No. 167 / 1998 Coll., on addictive substances and on the amendment of certain other laws, as amended by Act No. 273 / 2013 Coll.:
Government Regulation No. 463 / 2013 Coll., on substance lists, as amended by Government Regulation No. 243 / 2015 Coll., Government Regulation No. 46 / 2017 Coll., Government Regulation No. 30 / 2018 Coll. and Government Regulation No. 242 / 2018 Coll., is amended as follows:
1. At the end of footnote 3, the sentences are added to separate rows
"Commission Delegated Directive (EU) 2019 / 369 of 13 December 2018 amending the Annex to Council Framework Decision 2004 / 757 / JHA as regards the inclusion of new psychoactive substances in the definition of drugs.
Commission Delegated Directive (EU) 2020 / 1687 of 2 September 2020 amending the Annex to Council Framework Decision 2004 / 757 / JHA as regards the inclusion of the new psychoactive substance N, N-diethyl-2- [4- (1-methylethoxy) phenyl] methyl] -5-nitro-1H-benzimidazole-1-ethanamine (isotonitazene) in the definition of drug. '
2. Annex 3 shall read as follows:
"Annex No. 3 to Government Decree No. 463 / 2013 Coll.
List No 3 Narcotics
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Acetylbenzylfentanyl | NSC 73750; benzylacetylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)-acetamid | |
| Acetylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]acetamid | ||
| Acryloylfentanyl | Acrylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]prop-2-enamid | |
| AH-7921 | 3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid | ||
| AP-237 | bucinnazin; 1-N-butyryl-4-cinnamylpiperazine; | 1-[4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| Benzodioxolfentanyl | BZD-F; benzodioxole-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2H-1,3-benzodioxol-5-karboxamid | |
| Benzoylbenzylfentanyl | N-fenyl-N-(1-benzyl-piperidin-4-yl)benzamid | ||
| Benzoylfentanyl | fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]benzamid | |
| Benzylfentanyl | Benzyl-F; R 4129 | N-fenyl-N-[1-(fenylmethyl)piperidin-4-yl]propanamid | |
| Benzylfuranylfentanyl | Benzyl FuF | N-(1-benzylpiperidin-4-yl)-N-fenylfuran-2-karboxamid | |
| Bromadolin | U 4793e; U 47931E | 4-brom-N-(2-(dimethylamino)cyklohexyl)benzamid | |
| 4-Chlorisobutyrfentanyl | 4-Cl-iBF | N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| Cyklopentylfentanyl | Cyclopentyl-F; CP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid | |
| Cyklopropylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid | ||
| Desomorfin | 4,5α-epoxy-17-methylmorfinan-3-ol | ||
| Despropionyl-2-fluor fentanyl | N-(2-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Despropionyl-4-fluor fentanyl | N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Etorfin | (5R, 6R, 7R, 14R)-4,5-epoxy-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-6,14-ethenomorfinan-3-ol | ||
| Fentanyl butanamid analog | Butyrfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid | |
| 3-Fenylpropanoylfentanyl | β'-fenylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-3-fenylpropanamid | hydrocinnamoylfentanyl |
| 4-Fluor-butyrfentanyl | 4F-BF | N-(4-fluorfenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid | |
| 4-Fluor-cyklopropylbenzylfentanyl | para-fluorcyklopropylbenzyl-fentanyl | N-(4-fluorfenyl)-N-(1-benzylpiperidin-4-yl)-cyklopropankarboxamid | |
| 2-Fluorfentanyl | Ortofluorfentanyl | N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 2-FF, o-FF |
| 3-Fluorfentanyl | Metafluorfentanyl | N-(3-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 3-FF, m-FF |
| 4-Fluorfuranylfentanyl | para-fluorfuranylfentanyl; 4F-furanylfentanyl | N-(4-fluorfenyl)-N-(1-fenethylpiperidin-4-yl)furan-2-karboxamid | |
| 4-Fluorisobutyrfentanyl | 4F-iBF | N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| 3-Fluormethoxyacetylfentanyl | ortho-fluormethoxyacetyl-fentanyl | N-(3-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| Furanylfentanyl | FU-F; 2-furanoylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid | |
| (iso)Butyryl-F-fentanyl N-benzyl analog | N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid | ||
| Heroin | (5R,6S)-4,5-epoxy-17-methylmorfin-7-en-3,6-diyl-diacetát | ||
| 4-hydroxybutyrfentanyl | 4-HO-BF; para-hydroxybutyrylfentanyl | N-(4-hydroxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl]-butanamid | |
| Isopropyl-U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-(propan-2-yl)benzamid | ||
| Isotonitazen | N,N-diethyl-2-[[4-(1-methylethoxy)fenyl]methyl]-5-nitro-1H-benzimidazol-1-ethanamin | ||
| Ketobemidon | 1-[4-(3-hydroxyfenyl)-1-methylpiperidin-4-yl]propan-1-on | ||
| Konopí | S výjimkou konopí pro léčebné použití uvedené v seznamu č. 1 | ||
| Krotonylfentanyl | (2E)-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-2-butenamid | ||
| Methoxyacetylfentanyl | Methoxy-AcF | 2-methoxy-N-fenyl-N-1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| 4-Methoxybutyr fentanyl | 4-MeO-BF | N-(4-methoxyfenyl)-N-[ 1-(2-fenylethyl)piperidin-4-yl]butanamid | |
| 2-methylacetylfentanyl | o-methylacetylfentanyl | N-(2-methylfenyl)-N-[1-(2-fenylethyl)-piperidin-4-yl]-acetamid | |
| 2-methyl-AP-237 | 2-methyl-bucinnazin | 1-[2-methyl-4-(3-fenylprop-2-en-1-yl)piperazin-1-yl]butan-1-on | |
| 3,4-methylendioxy-U-47700 | 3,4-MDO-U-47700; 3,4-MDU-47700; MDU-47; MDU-47700 | N-(2-(dimethylamino)cyklohexyl)-N-methylbenzo[d][1,3]dioxol-5-karboxamid | |
| α-Methylfentanyl butanamid analog | BF; B-F | 2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid | |
| 3-methylkrotonylfentanyl | β'-methylkrotonylfentanyl | N-fenyl-N-[1-(2-fenylethyl)-piperidin-4-yl]-3-methylbut-2-enamid | |
| MT-45 | 1-cyklohexyl-4-(1,2-difenylethyl)piperazin | ||
| N-methyl U-47931E | N-methylbromadolin | 4-brom-N-(2-(dimethylamino)cyklohexyl)-N-methylbenzamid | |
| OCfentanyl | A-3217 | N-(2-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| Piperidylthiambuten | piperidinohton, PBN, 127C49 | 1-(4,4-di(thiofen-2-yl)but-3-en-2-yl)piperidin | |
| Pryskyřice z konopí | |||
| Tetrahydrofuranfentanyl | THF-F | N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid | |
| Tetramethylcyklopropanfentanyl | TMCP-fentanyl; TMCP-F | N-fenyl-N-1-(2-fenylethyl)piperidin-4-yl]-2,2,3,3-tetramethylcyklopropan-1-karboxamid | |
| Thiofenfentanyl | 2-thiofuranyl fentanyl | N-(1-fenethylpiperidin-4-yl)-N-fenylthiofen-2-karboxamid | |
| U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-48800 | 2-(2,4-dichlorfenyl)-N-(2-(dimethylamino)cyklohexyl)-N-methylacetamid | ||
| U-49900 | 3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-50488 | 3,4-dichlor-N-methyl-N-[2-(1-pyrrolidinyl)cyklohexyl] benzenacetamid | ||
| U-51754 | 2-(3,4-dichlorfenyl)-N-[2-(dimethylamino)cyklohexyl]-N-methylacetamid | ||
| Valerylfentanyl | TCE, VF | N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl]pentanamid; fentanyl pentanamid analog |
Including salts of narcotic substances listed in this list in all cases where such salts may exist. '
3. Annex 4 shall read as follows:
"Annex No 4 to Government Regulation No 463 / 2013 Coll.
List No 4 of psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| AB-CHMINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1(cyklohexylmethyl)-1H-indazol-3-karbox-amid | ||
| AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | ||
| AB-PINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid | ||
| 4-Acetoxy-N-methyl-N-ethyltryptamin | 4-AcO-MET | {3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl}acetát | |
| o-Acetylpsilocin | 4-AcO-DMT | {3-[2-(dimethylamino)ethyl]-1H-indol-4-yl}acetát | Psilacetin |
| ADB-CHMINACA | N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexylmethyl)-1H-indazol-3-karboxamid | ||
| ADB-FUBINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid | ||
| ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H- indazol-3-karboxamid | ||
| AL-LAD | (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]chinolin-9-karboxamid | 6-allyl-6-nor-LSD | |
| AM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| AMB-FUBINACA | FUB-AMB | Methyl 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát | MMB-FUBINACA |
| AMB-CHMICA | Methyl (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát | ||
| 5-Aminopropylindol | 5-API | 5-(2-aminopropyl)indol | |
| APICA | SDB-001, 2NE1 | N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid | |
| APINACA | N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid | AKB48 | |
| bk-PMA | 2-amino-1-(4-methoxyfenyl)propan-1-on | ||
| Methedron | bk-PMMA | 1-(4-methoxyfenyl)-2-(methylamino)propan-1-on | |
| BMDP | 3,4-MDBC | 2-benzylamino-1-(3,4-methylendioxyfenyl)propan-1-on | |
| 2-Brommethkathinon | 2-BMC | (RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on | |
| 3-Brommethkathinon | 3-BMC | (RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on | |
| 4-Brommethkathinon | 4-BMC | (RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on | Brefedron |
| 25B-NBOMe | 2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | Cimbi-36 | |
| 25C-NBOMe | 2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | 2C-C-NBOMe | |
| 25I-NBF; 25I-NB2F; 2C-I-NBF, NBF-2C-I; Cimbi-21 | 2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-fluorfenyl)methyl]ethylamin | ||
| 25I-NBOH | 2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol | 2C-I-NBOH; Cimbi-27 | |
| 25I-NBOMe | 2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | NBOMe-2C-I | |
| Bromo-Dragonfly | (2R)-1-(4-bromfuro[2,3-f] [1]benzofuran-8-yl)propan-2-amin | ||
| Butylon | Bk-MBDB | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]butan-1-on | Bl |
| 2-Chloramfetamin | 2-CA | 1-(2-chlorfenyl)propan-2-amin | |
| 3-Chloramfetamin | 3-CA | 1-(3-chlorfenyl)propan-2-amin | |
| 4-Chloramfetamin | 4-CA | 1-(4-chlorfenyl)propan-2-amin | PCA |
| 4-Chlor-N-butylkathinon | 4-CBC | 2-(butylamino)-1-(4-chlorfenyl)propan-1-on | 4-Chlorbutylkathinon |
| 2-Chlorethkathinon | 2-CEC | 1-(2-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Chlorethkathinon | 3-CEC | 1-(3-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Chlorethkathinon | 4-CEC | 1-(4-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 2C-E | 2-(4-ethyl-2,5-dimethoxyfenyl)ethan-1-amin | ||
| 2-Chlormethamfetamin | 2-CMA | 1-(2-chlorfenyl)-N-methylpropan-2-amin | |
| 3-Chlormethamfetamin | 3-CMA | 1-(3-chlorfenyl)-N-methylpropan-2-amin | |
| 4-Chlormethamfetamin | 4-CMA | 1-(4-chlorfenyl)-N-methylpropan-2-amin | p-CMA |
| 2-Chlormethkathinon | 2-CMC | 1-(2-chlorfenyl)-2-(methylamino)propan-1-on | |
| 3-Chlormethkathinon | 3-CMC | 1-(3-chlorfenyl)-2-(methylamino)propan-1-on | |
| 4-Chlormethkathinon | 4-CMC | 1-(4-chlorfenyl)-2-(methylamino)propan-1-on | Clefedron |
| 2-Chlorpentedron | 2-CPD | 1-(2-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 3-Chlorpentedron | 3-CPD | 1-(3-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Chlorpentedron | 4-CPD | 1-(4-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Chlor-α-pyrrolidinovalerofenon | 4-Cl-α-PVP | 1-(4-chlorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| CUMYL-4CN-BINACA | SGT-78 | 1-(4-kyanobutyl)-N-(1-methyl-1-fenylethyl)indazol-3-karboxamid | |
| Dimethoxyethylthiofenethylamin | 2C-T-2 | [4-(ethylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| Dimethoxypropylthiofenethylamin | 2C-T-7 | [4-(propylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| CP-47,497 | 2-[(1R,3S)-3-hydroxycyklohexyl]-5-(2-methyloktan-2-yl)fenol | ||
| CRA-13 | (naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon | CB-13 | |
| DBZP | 1,4-dibenzylpiperazin | ||
| Deschlorketamin | 2-(methylamino)-2-fenylcyklohexan-1-on | ||
| Deschlor-N-ethyl-ketamin | O-PCE; 2-Oxo-PCE, eticyclidone | 2-(ethylamino)-2-fenylcyklohexan-1-on | |
| Dibutylon | Bk-DMBDB | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon | Methylbutylon |
| Diclazepam | 2-chlorodiazepam | 7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | Ro 5-3448 |
| Diethyltryptamin | DET | N,N-diethyl-N-[2-(indol-3-yl)ethyl]amin | |
| Difenidin | DPD; 1,2-DEP; DIPH | 1-(1,2-difenylethyl)piperidin | AC1L4H21 |
| 5-Dihydrobenzofuranpyrovaleron | 5-DBFPV; MBPV | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| 3,4-Dichlormethylfenidát | 3,4-CTMP | methyl (2R)-2-(3,4-dichlorfenyl)-2-[(2R)-piperidin-2-yl]acetát | |
| Dimethoxyamfetamin | DMA | (2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin | |
| p-Methyl-4-methylaminorex | 4,4'-DMAR | 4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin | p4-DMAR |
| Dimethylheptyltetrahydrokanabinol | DMHP | 3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
| 2,3-Dimethylmetkathinon | 2,3-DMMC | 1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 2,4-Dimethylmetkathinon | 2,4-DMMC | 1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 3,4-Dimethylmetkathinon | 3,4-DMMC | 1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| Dimethyltriptamin | DMT | N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin | |
| Brolamfetamin | DOB | (2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin | |
| 2,5-Dimethoxy-4-chloramfetamin | DOC | 1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxyethylamfetamin | DOET | (2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxymetamfetamin | STP, DOM | (2RS)-1-(2,5-dimethoxy-4-methylfenyl)propan-2-amin | |
| 2,5-Dimethoxy-4-jodamfetamin | DOI | 1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin | |
| 5-EAPB | 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amin | ||
| 6-EAPB | 1-(1-benzofuran-6-yl)-N-ethylpropan-2-amin | ||
| Dimethylon | Bk-MDDMA | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-on | 3,4-methylendioxydi- methylkathinon |
| Methkathinon | Efedron | (2RS)-1-fenyl-2-(methylamino)propan-1-on | |
| Efenidin | NEDPA; ephenidine; EPE | N-ethyl-1,2-difenylethylamin | |
| Ephylon | MDEVP; bk-EBDP | 1-(benzo[d] [1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on | N-ethyl-pentylon |
| ETH-LAD | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindol-[4,3-fg]chinolin-9-karboxamid | ||
| Etizolam | AHR 3219; Depas | 4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin | |
| 4’-ethyl-α-PVP | 4'-ethyl-α-pyrrolidinopentiofenon | 1-(4-ethylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| Ethylfenidát | (RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát | ||
| N-ethylheptedron | Ethylheptedrone | 2-(ethylamino)-1-fenyl-heptan-1-on | |
| N-ethylhexedron | HEX-EN; Ethylhexedrone; Ethyl-Hex | 2-(ethylamino)-1-fenyl-hexan-1-on | |
| 2-Ethylmethkathinon | 2-EMC | (RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on | |
| 3-Ethylmethkathinon | 3-EMC | (RS)-2-methylamino-1-(3-ethylfenyl)propan-1-on | |
| 4-Ethylmethkathinon | 4-EMC | (RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on | |
| N-ethylnorpentedron | N-ethylpentedron | 2-(ethylamino)-1-fenyl-pentan-1-on | α-ethylaminopentiofenon |
| Etryptamin | 3-(2-aminobutyl)indol | ||
| Flualprazolam | Ro 11-5073/000 | 8-chlor-6-(2-fluorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a] [1,4]benzodiazepin | |
| 2-Fluoramfetamin | 2-FA | 1-(2-fluorfenyl)propan-2-amin | |
| 3-Fluoramfetamin | 3-FA | 1-(3-fluorfenyl)propan-2-amin | |
| 4-Fluoramfetamin | 4-FA | 1-(4-fluorfenyl)propan-2-amin | |
| 5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-AKB48 | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-AMB-PINACA | 5F-AMB | methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát | 5F-AMP |
| 5F-A-P7AICA | N-(adamantyl)-1-(5-fluoropentyl)-1H-pyrrolo[2,3-b]pyridine-3-car-boxamide | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-pyrrolo[2,3-b]pyridin-3-karboxamid | |
| 5F-EDMB-PINACA | ethyl 2-{[1-(5-fluorpentyl)-1H-indazol-3-karbonyl]amino}-3,3-dimethylbutanoát | ||
| 3F-Fenmetrazin | 3-FPM; PAL-593 | 2-(3-fluorofenyl)-3-methylmorfolin | |
| 4F-Fenmetrazin | 4-FPM | 2-(4-fluorofenyl)-3-methylmorfolin | |
| 5F-JWH-398 | CL-2201; JWH-398 N-(5-fluorpentyl) analog | (4-chlornaftalen-1-yl)[1-(5-fluorpentyl)-1H-indol-3-yl]-methanon | |
| 2-Fluordeschlorketamin | 2-Fl-2'-Oxo-PCM, fluoroketamine 2-FDCK, 2-FDK, 2-FK | 2-(2-fluorfenyl)-2-methylamino-cyklohexanon | |
| 3-Fluorethamfetamin | 3-fluoroethylamphetamine; 3-FEA | N-ethyl-1-(3-fluorfenyl)propan-2-amin; N-ethyl-3-fluoramfetamin | |
| 2-Fluorethkathinon | 2-FEC | 1-(2-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Fluorethkathinon | 3-FEC | 1-(3-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Fluorethkathinon | 4-FEC | 1-(4-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 2-Fluormethamfetamin | 2-FMA | (RS)-1-(2-fluorfenyl)-N-methylpropan-2-amin | |
| 3-Fluormethamfetamin | 3-FMA | (RS)-1-(3-fluorfenyl)-N-methylpropan-2-amin | |
| 4-Fluormethamfetamin | 4-FMA | (RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin | |
| 2-Fluormethkathinon | 2-FMC | 1-(2-fluorfenyl)-2-(methylamino)propan-1-on | |
| 3-Fluormethkathinon | 3-FMC | 1-(3-fluorfenyl)-2-(methylamino)propan-1-on | |
| 4-Fluormethkathinon | 4-FMC | 1-(4-fluorfenyl)-2-(methylamino)propan-1-on | Flefedron |
| 4-Fluormethylfenidát | 4F-MPH; 4-FMPH | Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | 4F-TMP |
| 4-Fluorpentedron | 4-FPD; 4-F-pentedron | 1-(4-fluorfenyl)-2-(methylamino)pentan-1-on | |
| 5F-PB-22; 5F-QUPIC | 8-chinolinyl ester kyseliny 1-(5-fluorpentyl)-1H-indol-3-karboxylové | ||
| 4F-MDMB-BICA | methyl (S)-2-({[1-(4-fluorbutyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | ||
| 4F-MDMB-BINACA | 4F-ADB | methyl (S)-2-({[1-(4-fluorbutyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | |
| 5F-MDMB-PICA | 5F-MDMB-2201 | methyl (S)-2-({[1-(5-fluorpentyl)-1H-indol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | |
| 5F-MDMB-PINACA | 5F-ADB | methyl (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | |
| 5FUR-144 | [1-(5-fluorpentyl)-1H-indol-3-yl] (2,2,3,3-tetramethylcyklopropyl)methanon | XLR-11 | |
| Hexylon | βk-MBDH | 1-(1,3-benzodioxol-5 -yl)-2-(methylamino)hexan-1-on | |
| 4-Hydroxy-N-methyl-N-ethyl tryptamin | 4-HO-MET | 3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol | Metocin; Methylcybin |
| 4-Hydroxy-N-methyl-N-isopropyl tryptamin | 4-HO-MiPT | 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol | Miprocin |
| Hydroxytenamfetamin | (2RS)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin | ||
| Joddimethoxyfenethylamin | 2C-I | (4-jod-2,5-dimethoxyfenylethyl)amin | |
| JWH-018 | (naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-073 | (1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| JWH-081 | (4-methoxynaftalen-1-yl)(l -pentyl-1H-indol-3-yl)methanon | ||
| JWH-122 | (4-methylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-200 | 1-(2-morfolinoethyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| JWH-210 | (4-ethylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-250 | 2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on | ||
| JWH-398 | (4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| Kathinon | (2S)-2-amino-1-fenylpropan-1-on | ||
| Klonazolam | 6-(2-chlorfenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| (+)-Lysergid | LSD, LSD-25 | (+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin | |
| lp-LSD, 1P-LAD | diethylamid kyseliny 1-propionyl lysergové; (6aR,9R)-N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid | ||
| 5-MeO-MiPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-methoxy-N-methyl-N-iso-propyl tryptamin | ||
| Methoxfenidin | MXP | 1-[1-(2-methoxyfenyl)-2-fenylethyl]piperidin | 2-MeO-difenidin |
| 2-Methylamfetamin | 2-MA | (2RS)-1-(2-methylfenyl)propan-2-amin | |
| 3-Methylamfetamin | 3-MA | (2RS)-1-(3-methylfenyl)propan-2-amin | |
| 4-Methylamfetamin | 4-MA | (2RS)-1-(4-methylfenyl)propan-2-amin | |
| 2-MAPB | 1-(benzofuran-2-yl)-N-methylpropan-2-amin | ||
| 3-MAPB | 1-(benzofuran-3-yl)-N-methylpropan-2-amin | ||
| 4-MAPB | 1-(benzofuran-4-yl)-N-methylpropan-2-amin | ||
| 5-MAPB | 1-(benzofuran-5-yl)-N-methylpropan-2-amin | ||
| 6-MAPB | 1-(benzofuran-6-yl)-N-methylpropan-2-amin | ||
| 7-MAPB | 1-(benzofuran-7-yl)-N-methylpropan-2-amin | ||
| MBZP | 1-benzyl-4-methylpiperazin | ||
| 2-Methyl-N,N-dimethylkathinon | 2-MDMC | 1-(2-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 3-Methyl-N,N-dimethylkathinon | 3-MDMC | 1-(3-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 4-Methyl-N,N-dimethylkathinon | 4-MDMC | 1-(4-methylfenyl)-2-(dimethylamino)propan-1-on | |
| m-Chlorfenylpiperazin | mCPP | 1-(3-chlorfenyl)piperazin | |
| Tenamfetamin | MDA | (2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| MDAI | 5,6-(methylendioxy)indan-2-amin | ||
| Ethyltenamfetamin | MDE, MDEA | (2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Ethylon | bk-MDEA | 2-ethylamino-1-(3,4-methylendioxyfenyl)propan-1-on | |
| Methyltenamfetamin | MDMA | (2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| MDMB-CHMICA | N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methyl ester | ||
| MDMB-4en-PINACA | (methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazol-3-karboxamido) butanoát) | ||
| MDMB-FUBINACA | 2-[[1-[(4-fluorfenyl)methyl]indazol-3-karbonyl]amino]-3,3-dimethylbutanoát | ||
| MDPHP; 3,4-MDPHP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on | ||
| 2,3-Methylendioxymethkathinon | 2,3-MDMC | 1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on | |
| 3,4-Methylendioxypyrovaleron | MDPV | 1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on | MDPK |
| 2-Methylethkathinon | 2-MEC | 2-(ethylamino)-1-(2-methylfenyl)propan-1-on | |
| 3-Methylethkathinon | 3-MEC | 2-(ethylamino)-1-(3-methylfenyl)propan-1-on | |
| 4-Methylethkathinon | 4-MEC | 2-(ethylamino)-1-(4-methylfenyl)propan-1-on | |
| 4-Methylmetkathinon | Mefedron | 2-(methylamino)-1-(4-methylfenyl)propan-1-on | |
| 5-MeO-AMT | 5 -methoxy-α-methyltryptamin | ||
| 5-MeO-DALT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin | ||
| 3-Methoxyfencyklidin | 3-MeO-PCP | 1-[1-(3-methoxyfenyl)cyklohexyl]piperidin | |
| Meskalin | 3,4,5-trimethoxyfenethylamin | ||
| Methoxetamin | MXE | 2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon | |
| Methylaminorex | (±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin | ||
| 2-Methyl-N-ethylnorpentedron | 2-MEAP | 2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on | |
| 3-Methyl-N-ethylnorpentedron | 3-MEAP | 2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on | |
| 4-Methyl-N-ethylnorpentedron | 4-MEAP | 2-(ethylamino)-1-(4-methylfenyl)-pentan-1-on | |
| Methylon | Bk-MDMA | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on | |
| 2-Methylmetamfetamin | 2-MMA | 1-(2-methylfenyl)-N-methylpropan-2-amin | |
| 3-Methylmetamfetamin | 3-MMA | 1-(3-methylfenyl)-N-methylpropan-2-amin | |
| 4-Methylmetamfetamin | 4-MMA | 1-(4-methylfenyl)-N-methylpropan-2-amin | |
| 2-Methylmetkathinon | 2-MMC | 2-(methylamino)-1-(2-methylfenyl)propan-1-on | |
| 3-Methylmetkathinon | 3-MMC | 2-(methylamino)-1-(3-methylfenyl)propan-1-on | |
| Methoxytenamfetamin | MMDA | (2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin | |
| 4-MPD | 1-(4-methylfenyl)-2-methylamino-pentan-1-on | ||
| Methylthienylpropamin | MPA | N-methyl-1-(thiofen-2-yl)propan-2-amin | |
| 2-Methylthioamfetamin | 2-MTA | (2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin | |
| 3-Methylthioamfetamin | 3-MTA | (2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin | |
| 4-Methylthioamfetamin | 4-MTA | (2RS)-1-[4-(methylsulfanyl)fenyl]propan-2-amin | |
| Mexedron | 4-MMC-oMe; MEX | (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on | |
| Naftylpyrovaleron | Nafyron | 1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on | O-2482 |
| N-methyl-2-aminoindan | N-methyl-2AI | 2,3-dihydro-N-methyl-1H-inden-2-amin | NM-2AI |
| NM-2201, CBL-2201 | naftalen-1-yl-1-(5-fluorpentyl)-1H-indol-3-karboxylát | ||
| o-Desmethyltramadol | ODT | 3-{-2-[(dimethylamino)methyl]-1-hydroxycyklohexyl}fenol | |
| Parahexyl | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | ||
| Eticyklidin | PCE | N-ethyl-1-fenylcyklohexylamin | |
| Pentedron | pentedron | 1-fenyl-2-(methylamino)pentan-1-on | |
| Pentylon | Methylendioxypentedron; βk-MBDP | (±)-1 -(1,3-benzodioxol-5-yl)-2-(methylamino)pentan-1-on | |
| p-Fluorfenylpiperazin | pFPP | 1-(4-fluorfenyl)piperazin | |
| Methoxyamfetamin | PMA | (2RS)-1-(4-methoxyfenyl)propan-2-amin | |
| Methoxymetamfetamin | PMMA | 1-(4-methoxyfenyl)-N-methylpropan-2-amin | |
| Psilocybin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogenfosfát | ||
| Psilocin | Psilotsin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | |
| PV8, α-PHPP | 1-fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on | ||
| PV9, α-POP | 1-fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on | ||
| α-PVP | 1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | ||
| α-PVT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on | ||
| α-Pyrrolidinohexanofenon | α-PHP | 1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on | |
| α-Pyrrolidinoisohexanofenon | α-PiHP | 1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | |
| Rolicyklidin | PHP, PCPY | 1-(1-fenylcyklohexyl)pyrrolidin | |
| Salvinorin A | Salvinorin A | methyl-(2RS,4aR,6aR,7R,9RS,10aRS,10bR)-9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododekahydro-1H-benzo[ƒ]isochromen-7-karboxylát | |
| Tenocyklidin | TCP | 1-[1-(2-thienyl)cyklohexyl]piperidin | |
| 1-(3-Trifluormethylfenyl)piperazin | TFMPP | 1-[3-(trifluormethyl)fenyl]piperazin | |
| Tetrahydrokanabinol | THC | Δ6a(10a)-, Δ6a(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly a jejich stereoizomery | |
| THJ-2201 | 5F-JWH-018-N, 5F-THJ-018, AM-2201 indazol analog | [1-(5 -fluorpentyl)-1H-indazol-3-yl] (1-naftyl)methanon | |
| TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on | ||
| Trimethoxyamfetamin | TMA | (2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin | |
| Trimethoxyamfetamin-2 | TMA-2 | (2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin | |
| 2,4,6-Trimethoxyamfetamin | TMA-6 | 1-(2,4,6-trimethoxyfenyl)propan-2-amin | |
| UR-144 | (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyklopropyl)methanon | TMCP-018 | |
| W-15 | 4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid | ||
| W-18 | 4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid |
Including stereoisomers of psychotropic substances, except for the explicit exceptions listed in this list in all cases where such stereoisomers may exist according to the specific chemical labelling and salts of psychotropic substances listed in this list in all cases where such salts may exist. ';
4. Annex 7 shall read as follows:
"Annex No 7 to Government Decree No. 463 / 2013 Coll.
List No 7 psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce | Další mezinárodní nechráněný název nebo obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| Allobarbital | 5,5-diallylbarbiturová kyselina | ||
| Alprazolam | 8-chlor-6-fenyl-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Amfepramon | 2-(diethylamino)-1-fenylpropan-1-on | ||
| Aminorex | 5-fenyl-4,5-dihydrooxazol-2-amin | ||
| Barbital | 5,5-diethylbarbiturová kyselina | ||
| Bentazepam | CI 718; QM 6008; Thiadipone; | 5-fenyl-1,3,6,7,8,9-hexahydro-2H-[1]benzothieno[2,3-e] [1,4]diazepin-2-on | |
| Benzfetamin | (+)-N-benzyl-N-(2-fenyl-1-methylethyl)-N-methylamin | ||
| Benzylpiperazin | 1-benzylpiperazin | ||
| Bromazepam | 7-brom-5-(2-pyridyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Brotizolam | 2-brom-4-(2-chlorfenyl)-9-methyl-6H-thieno[3,2-ƒ][1,2,4]triazolo[4,3-a][1,4]diazepin | ||
| Butobarbital | 5-butyl-5-ethylbarbiturová kyselina | ||
| Cinazepam | BD-798; | 4-[[7-brom-5-(2-chlorfenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]oxy]-4-oxo-butanová kyselina | |
| Delorazepam | 7-chlor-5-(2-chlorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Diazepam | 7-chlor-5-fenyl-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Estazolam | 8-chlor-6-fenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Ethinamát | N-(1-ethynylcyklohexyl)karbamát | ||
| Ethchlorvynol | 1-chlor-3-ethylpent-1-en-4-yn-3-ol | ||
| Ethylamfetamin | (±)-2-(ethylamino)-1-fenylpropan | ||
| Ethylloflazepát | ethyl-7-chlor-5-(2-fluorfenyl)-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-karboxylát | ||
| Fenazepam | 7-Bromo-5-(2-chlorofenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Fendimetrazin | (2S,3S)-2-fenyl-3,4-dimethylmorfolin | ||
| Fenkamfamin | (±)-2-(ethylamino)-3-fenylbicyklo[2.2.1]heptan | ||
| Fenobarbital | 5-ethyl-5-fenylbarbiturová kyselina | ||
| Fenproporex | (+)-1-fenyl-2-[(2-kyanethyl)amino] propan | ||
| Fludiazepam | 7-chlor-5-(2-fluorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Flurazepam | 7-chlor-2-[2-(diethylamino)ethyl]-5-(2-fluorfenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Halazepam | 7-chlor-5-fenyl-1-(2,2,2-trifluorethyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Haloxazolam | 10-brom-11b-(2-fluorfenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-on | ||
| Chlordiazepoxid | 7-chlor-5-fenyl-2-(methylamino)-3H-1,4-benzodiazepin-4-oxid | ||
| Kamazepam | 7-chlor-5-fenyl-1-methyl-2-oxo-1,3-dihydro-2H-1,4-benzodiazepin-3-yl-dimethylkarbamát | ||
| Ketamin | (2RS)-2-(2-chlorfenyl)-2-(methylamino)cyklohexan-1-on | ||
| Ketazolam | 11-chlor-12b-fenyl-2,8-dimethyl-8,12b-dihydro-4H-[1,3]oxazino[3,2-d][1,4]benzodiazepin-4,7(6H)-dion | ||
| Klobazam | 7-chlor-5-fenyl-1-methyl-1H-1,5-benzodiazepin-2,4(3H,5H)-dion | ||
| Klonazepam | 5-(2-chlorfenyl)-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Klorazepát | 7-chlor-5-fenyl-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-3-karboxylová kyselina | ||
| Klotiazepam | 5-(2-chlorfenyl)-7-ethyl-1-methyl-1,3-dihydro-2H-thieno[2,3-e][1,4]diazepin-2-on | ||
| Kloxazolam | 10-chlor-11b-(2-chlorfenyl)-2,3,7,11b-tetrahydrooxazolo[3,2-d][1,4]benzodiazepin-6(5H)-on | ||
| Lefetamin | SPA | (-)-1-(dimethylamino)-1,2-difenylethan | |
| Loprazolam | 6-(2-chlorfenyl)-2-[(4-methylpiperazin-1-yl)methyl]-8-nitro-2,4-dihydro-1H-imidazo[1,2-a][1,4]benzodiazepin-1-on | ||
| Lorazepam | 7-chlor-5-(2-chlorfenyl)-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Lormetazepam | 7-chlor-5-(2-chlorfenyl)-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Mazindol | 5-(4-chlorfenyl)-2,5-dihydro-3H-imidazo[2.1-α]-isoindol-5-ol | ||
| Medazepam | 7-chlor-5-fenyl-1-methyl-2,3-dihydro-1H-1,4-benzodiazepin | ||
| Mefenorex | (±)-2-[(3-chlorpropyl)amino]-1-fenylpropan | ||
| Meprobamát | 2-methyl-2-propylpropan-1,3-diyl-dikarbamát | ||
| Mesokarb | N-(fenylkarbamoyl)-3-(2-fenyl-1-methylethyl)sydnonimin | ||
| Methylfenobarbital | 5-ethyl-5-fenyl-1-methylbarbiturová kyselina | ||
| Methyprylon | 3,3-diethyl-5-methylpiperidin-2,4-dion | ||
| Midazolam | 8-chlor-6-(2-fluorfenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepin | ||
| Nimetazepam | 5-fenyl-1-methyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Nitrazepam | 5-fenyl-7-nitro-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Nordazepam | 7-chlor-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Oxazepam | 7-chlor-5-fenyl-3-hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Oxazolam | 10-chlor-11b-fenyl-2-methyl-2,3,7,11b-tetrahydrooxazolo[3,2-d] [1,4]benzodiazepin-6(5H)-on | ||
| Pemolin | 5-fenyl-2-imino-1,3-oxazolidin-4-on | ||
| Pinazepam | 7-chlor-5-fenyl-1-(prop-2-yn-1-yl)-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Pipradrol | difenyl(2-piperidyl)methanol | ||
| Prazepam | 7-chlor-1-(cyklopropylmethyl)-5-fenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Pyrovaleron | (+)-1-(4-methylfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | ||
| Sekbutabarbital | 5-ethyl-5-(1-methylpropyl)barbiturová kyselina | ||
| Temazepam | (RS)-7-chlor-5-fenyl-3-hydroxy-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Tetrazepam | 7-chlor-5-(cyklohex-1-en-1-yl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | ||
| Triazolam | 8-chlor-6-(2-chlorfenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin | ||
| Vinylbital | 5-(1-methylbutyl)-5-vinylbarbiturová kyselina | ||
| Zolpidem | N,N,6-trimethyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-acetamid |
Including salts of psychotropic substances listed in this list in all cases where such salts may exist. '
Technical Regulation
This Regulation has been notified in accordance with Directive (EU) 2015 / 1535 of the European Parliament and of the Council of 9 September 2015 laying down a procedure for the provision of information in the field of technical and information society services.
Efficacy
This Regulation shall enter into force on 3 June 2021.
Prime Minister:
Ing. Babiš v. r.
Minister for Health:
Prof. MUDr. Arenberger, DrSc., MBA, v. r.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Government Regulation No. 184 / 2021 Coll., amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended |
|---|---|
| Regulation Type | Regulation |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 07.05.2021 |
|---|---|
| Effective from | 03.06.2021 |
| Effective until | - |
| Status | Valid |
Legal Areas:
Administrative law
Health
The regulation text is for informational purposes only.
Comments 0